Precigen Inc. (PGEN) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts PGEN Hot Sheet
Join SI Premium – FREE
Precigen Inc. (NASDAQ: PGEN) reported Q2 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $2.18 million.
For earnings history and earnings-related data on Precigen Inc. (PGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
- Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
